Moradi Y, Lee J, Armani A
ACS Sens. 2023; 9(1):52-61.
PMID: 37955934
PMC: 10825864.
DOI: 10.1021/acssensors.3c01437.
Yang M, Li Y, Kong L, Huang S, He L, Liu P
J Clin Invest. 2023; 133(14).
PMID: 37463446
PMC: 10348774.
DOI: 10.1172/JCI164428.
Senger K, Yuan W, Sagolla M, Doerr J, Bolon B, Ziai J
Adv Genet (Hoboken). 2023; 2(1):e10036.
PMID: 36618440
PMC: 9744554.
DOI: 10.1002/ggn2.10036.
Gu Y, Gao H, Zhang H, John A, Zhu X, Shivaram S
Oncogene. 2022; 41(35):4119-4129.
PMID: 35864174
PMC: 9417995.
DOI: 10.1038/s41388-022-02415-6.
Vo J, Wu Y, Mishler J, Hall S, Mannan R, Wang L
Nat Commun. 2022; 13(1):3750.
PMID: 35768438
PMC: 9243087.
DOI: 10.1038/s41467-022-31430-0.
Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem.
Wahdan-Alaswad R, Liu B, Thor A
Cancer Drug Resist. 2022; 3(2):179-198.
PMID: 35582612
PMC: 9090587.
DOI: 10.20517/cdr.2019.92.
Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology.
Gan S, Phua S, Yeo J
Antib Ther. 2022; 5(1):63-72.
PMID: 35372784
PMC: 8972324.
DOI: 10.1093/abt/tbac005.
Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffolds.
Rabionet M, Polonio-Alcala E, Relat J, Yeste M, Sims-Mourtada J, Kloxin A
Mater Today Bio. 2021; 12:100155.
PMID: 34841239
PMC: 8606546.
DOI: 10.1016/j.mtbio.2021.100155.
Somatic Mutations in and Implications for Current Treatment Paradigms in -Positive Breast Cancer.
Gaibar M, Beltran L, Romero-Lorca A, Fernandez-Santander A, Novillo A
J Oncol. 2020; 2020:6375956.
PMID: 32256585
PMC: 7081042.
DOI: 10.1155/2020/6375956.
Peptide-Based Vaccines: Current Progress and Future Challenges.
Malonis R, Lai J, Vergnolle O
Chem Rev. 2019; 120(6):3210-3229.
PMID: 31804810
PMC: 7094793.
DOI: 10.1021/acs.chemrev.9b00472.
Identification of core differentially methylated genes in glioma.
Xue J, Gao H, Sang W, Cui W, Liu M, Zhao Y
Oncol Lett. 2019; 18(6):6033-6045.
PMID: 31788078
PMC: 6864971.
DOI: 10.3892/ol.2019.10955.
Elimination of Osteosarcoma by Necroptosis with Graphene Oxide-Associated Anti-HER2 Antibodies.
Xiao H, Jensen P, Chen X
Int J Mol Sci. 2019; 20(18).
PMID: 31491952
PMC: 6770144.
DOI: 10.3390/ijms20184360.
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and -Mutated Breast Cancer.
Collins D, Conlon N, Kannan S, Verma C, Eli L, Lalani A
Cancers (Basel). 2019; 11(6).
PMID: 31141894
PMC: 6628314.
DOI: 10.3390/cancers11060737.
GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway.
Zhang X, Ni B, Li Q, Hu L, Jiang S, Li R
J Exp Clin Cancer Res. 2019; 38(1):214.
PMID: 31118109
PMC: 6532258.
DOI: 10.1186/s13046-019-1218-8.
Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance.
Nava M, Dutta P, Farias-Eisner R, Vadgama J, Wu Y
Sci Rep. 2019; 9(1):5141.
PMID: 30914750
PMC: 6435657.
DOI: 10.1038/s41598-019-41672-6.
Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.
Nava M, Dutta P, Zemke N, Farias-Eisner R, Vadgama J, Wu Y
BMC Med Genomics. 2019; 12(1):32.
PMID: 30736768
PMC: 6368760.
DOI: 10.1186/s12920-019-0477-8.
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations.
Pahuja K, Nguyen T, Jaiswal B, Prabhash K, Thaker T, Senger K
Cancer Cell. 2018; 34(5):792-806.e5.
PMID: 30449325
PMC: 6248889.
DOI: 10.1016/j.ccell.2018.09.010.
Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2.
Tobin S, Wakefield D, Jones V, Liu X, Schmolze D, Jovanovic-Talisman T
Sci Rep. 2018; 8(1):15154.
PMID: 30310083
PMC: 6181918.
DOI: 10.1038/s41598-018-33225-0.
Linear Chains of HER2 Receptors Found in the Plasma Membrane Using Liquid-Phase Electron Microscopy.
Parker K, Trampert P, Tinnemann V, Peckys D, Dahmen T, de Jonge N
Biophys J. 2018; 115(3):503-513.
PMID: 30099989
PMC: 6084255.
DOI: 10.1016/j.bpj.2018.06.016.
Quantification of Circulating Cancer Biomarkers via Sensitive Topographic Measurements on Single Binder Nanoarrays.
Ambrosetti E, Paoletti P, Bosco A, Parisse P, Scaini D, Tagliabue E
ACS Omega. 2018; 2(6):2618-2629.
PMID: 30023671
PMC: 6044866.
DOI: 10.1021/acsomega.7b00284.
